Appointments at BiPar Sciences
This article was originally published in Scrip
Executive Summary
BiPar Sciences, a private US biopharmaceutical company developing PARP inhibitors as cancer therapies, has appointed Sunil Patel vice-president of corporate development and marketing, and Adrienne Weil legal counsel. Mr Patel previously served as vice-president of corporate development at Allos Therapeutics, while Ms Weil formerly worked at the law offices of Orrick, Herrington & Sutcliffe.
You may also be interested in...
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.